![semaglutide hepatic impairment pharmacokinetics Prediction of the of the GLP-1 receptor agonist in humans via a population pharmacokinetic model integrating interspecies scaling | Journal of Pharmaceutical Investigation PDF] Safety, tolerability, pharmacokinetics, and](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40005-024-00717-3/MediaObjects/40005_2024_717_Fig1_HTML.png)
semaglutide hepatic impairment pharmacokinetics Prediction of the of the GLP-1 receptor agonist in humans via a population pharmacokinetic model integrating interspecies scaling | Journal of Pharmaceutical Investigation PDF] Safety, tolerability, pharmacokinetics, and
EUR27.40
EUR75.40
Pay in 4 interest-free payments of $6.85 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
![semaglutide hepatic impairment pharmacokinetics Prediction of the of the GLP-1 receptor agonist in humans via a population pharmacokinetic model integrating interspecies scaling | Journal of Pharmaceutical Investigation PDF] Safety, tolerability, pharmacokinetics, and](https://figures.semanticscholar.org/e338e8f8bf819030be1ae81167c7d20946acbbb5/6-Table1-1.png)
![semaglutide hepatic impairment pharmacokinetics Prediction of the of the GLP-1 receptor agonist in humans via a population pharmacokinetic model integrating interspecies scaling | Journal of Pharmaceutical Investigation PDF] Safety, tolerability, pharmacokinetics, and](https://www.dovepress.com/article/fulltext_file/506957/aW1n/DDDT_A_506957_O_F0003g.jpg)
![semaglutide hepatic impairment pharmacokinetics Prediction of the of the GLP-1 receptor agonist in humans via a population pharmacokinetic model integrating interspecies scaling | Journal of Pharmaceutical Investigation PDF] Safety, tolerability, pharmacokinetics, and](https://www.researchgate.net/publication/324760355/figure/fig4/AS:619466891227137@1524703824804/Mean-concentration-time-profiles-of-SNAC-after-the-10th-dose-by-hepatic-function-group.png)
